Chemours (CC) Research & Development (2014 - 2026)

Chemours' Research & Development history runs 13 years deep, the most recent figure standing at $26.0 million for Q1 2026.

• On a quarterly basis, Research & Development fell 3.7% year-over-year to $26.0 million in Q1 2026; TTM through Mar 2026 was $107.0 million, a 0.93% decrease from a year earlier, with the FY2025 full-year figure at $108.0 million, down 0.92% from the prior year.
• Research & Development slipped to $26.0 million in Q1 2026 per CC's latest filing, from $27.0 million in the prior quarter.
• Across five years, Research & Development topped out at $32.0 million in Q3 2022 and bottomed at $25.0 million in Q2 2022.
• The 5-year median for Research & Development is $27.0 million (2025), against an average of $27.5 million.
• Across the five-year window, Research & Development advanced 25.0% in 2022 and dropped 13.33% in 2023, its largest moves.
• Year by year, Research & Development stood at $30.0 million in 2022, then fell by 13.33% to $26.0 million in 2023, then changed by 0.0% to $26.0 million in 2024, then climbed by 3.85% to $27.0 million in 2025, then fell by 3.7% to $26.0 million in 2026.
• Per Business Quant, the three latest CC Research & Development figures stand at $26.0 million (Q1 2026), $27.0 million (Q4 2025), and $26.0 million (Q3 2025).